These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 15793663)
1. Time intervals (3' or 5') between dose steps can influence methacholine challenge test. Mariotta S; Sposato B; Ricci A; De Clementi F; Mannino F Lung; 2005; 183(1):1-11. PubMed ID: 15793663 [TBL] [Abstract][Full Text] [Related]
2. Comparison of percentage fall in FVC at the provocative concentration of methacholine causing a 20% fall in FEV(1) between patients with asymptomatic bronchial hyperresponsiveness and mild asthma. Yoo Y; Choung JT; Yu J; Kim DK; Choi SH; Koh YY Chest; 2007 Jul; 132(1):106-11. PubMed ID: 17505037 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of methacholine challenge tests assessing airway hyperreactivity in asthmatic patients - a multifunctional approach. Kraemer R; Smith HJ; Sigrist T; Giger G; Keller R; Frey M Respir Res; 2016 Nov; 17(1):154. PubMed ID: 27855687 [TBL] [Abstract][Full Text] [Related]
4. Methacholine dry powder inhaler as a new tool for bronchial challenge test. Colombo G; Terzano C; Colombo P; Petroianni A; Ricci A; Buttini F Int J Pharm; 2008 Mar; 352(1-2):165-71. PubMed ID: 18055141 [TBL] [Abstract][Full Text] [Related]
5. Comparison of mannitol and methacholine to predict exercise-induced bronchoconstriction and a clinical diagnosis of asthma. Anderson SD; Charlton B; Weiler JM; Nichols S; Spector SL; Pearlman DS; Respir Res; 2009 Jan; 10(1):4. PubMed ID: 19161635 [TBL] [Abstract][Full Text] [Related]
6. Bronchial responsiveness to adenosine 5'-monophosphate (AMP) and methacholine differ in their relationship with airway allergy and baseline FEV(1). De Meer G; Heederik D; Postma DS Am J Respir Crit Care Med; 2002 Feb; 165(3):327-31. PubMed ID: 11818315 [TBL] [Abstract][Full Text] [Related]
7. Current Asthma Prevalence Using Methacholine Challenge Test in Korean Children from 2010 to 2014. Woo H; Samra MS; Lim DH; Kim JH J Korean Med Sci; 2021 May; 36(19):e130. PubMed ID: 34002550 [TBL] [Abstract][Full Text] [Related]
9. The determinants of bronchial hyperresponsiveness in patients with allergic rhinitis. Mete N; Sin A; Gulbahar O; Erdinc M; Sebik F; Kokuludag A Ann Allergy Asthma Immunol; 2004 Aug; 93(2):193-9. PubMed ID: 15328682 [TBL] [Abstract][Full Text] [Related]
10. Bronchial hyperreactivity to methacholine in atopic versus nonatopic asthmatic schoolchildren and preschoolers. Castro-Rodriguez JA; Navarrete-Contreras P; Holmgren L; Sanchez I; Caussade S J Asthma; 2010 Oct; 47(8):929-34. PubMed ID: 20831466 [TBL] [Abstract][Full Text] [Related]
11. Adenosine dry powder inhalation for bronchial challenge testing, part 2: proof of concept in asthmatic subjects. Lexmond AJ; van der Wiel E; Hagedoorn P; Bult W; Frijlink HW; ten Hacken NH; de Boer AH Eur J Pharm Biopharm; 2014 Sep; 88(1):148-52. PubMed ID: 24780441 [TBL] [Abstract][Full Text] [Related]
12. Exercise, methacholine, and adenosine 5'-monophosphate challenges in children with asthma: relation to severity of the disease. Avital A; Godfrey S; Springer C Pediatr Pulmonol; 2000 Sep; 30(3):207-14. PubMed ID: 10973039 [TBL] [Abstract][Full Text] [Related]
13. Allergic rhinitis phenotypes based on bronchial hyperreactivity to methacholine. Ciprandi G; Ricciardolo FL; Schiavetti I; Cirillo I Am J Rhinol Allergy; 2014; 28(6):214-8. PubMed ID: 25514477 [TBL] [Abstract][Full Text] [Related]
14. Methacholine challenge--comparison of an ATS protocol to a new rapid single concentration technique. Schulze J; Rosewich M; Riemer C; Dressler M; Rose MA; Zielen S Respir Med; 2009 Dec; 103(12):1898-903. PubMed ID: 19596563 [TBL] [Abstract][Full Text] [Related]
15. Sulforaphane improves the bronchoprotective response in asthmatics through Nrf2-mediated gene pathways. Brown RH; Reynolds C; Brooker A; Talalay P; Fahey JW Respir Res; 2015 Sep; 16(1):106. PubMed ID: 26369337 [TBL] [Abstract][Full Text] [Related]
17. Differences in the effect of allergen avoidance on bronchial hyperresponsiveness as measured by methacholine, adenosine 5'-monophosphate, and exercise in asthmatic children. Benckhuijsen J; van den Bos JW; van Velzen E; de Bruijn R; Aalbers R Pediatr Pulmonol; 1996 Sep; 22(3):147-53. PubMed ID: 8893252 [TBL] [Abstract][Full Text] [Related]
18. Airway hyperresponsiveness: a comparative study of methacholine and exercise challenges in seasonal allergic rhinitis with or without asthma. Sin BA; Yildiz OA; Dursun AB; Misirligil Z; Demirel YS J Asthma; 2009 Jun; 46(5):486-91. PubMed ID: 19544170 [TBL] [Abstract][Full Text] [Related]
19. Doses and models in risk assessment analysis for bronchial hyperresponsiveness. de Marco R; Bugiani M; Zanolin E; Verlato G; Rijcken B J Clin Epidemiol; 1998 Jan; 51(1):19-28. PubMed ID: 9467631 [TBL] [Abstract][Full Text] [Related]
20. Provocative dose of methacholine causing a 20% drop in FEV1 should be used to interpret methacholine challenge tests with modern nebulizers. Dell SD; Bola SS; Foty RG; Marshall LC; Nelligan KA; Coates AL Ann Am Thorac Soc; 2015 Mar; 12(3):357-63. PubMed ID: 25575246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]